16h
GlobalData on MSNRegeneron’s macular oedema therapy shows promise in Phase III trialIn the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.
Macular degeneration is a condition that affects the retina, which is neural tissue that lines the back of the eye, like wallpaper in a room. There is an important area ...
Optometrists may not surgically repair macular holes, but they play a crucial role in managing visual outcomes in these ...
For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.
Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
Modern cataract surgery is a safe, effective procedure, but it wasn't always this way. The earliest record dates back to the fifth century BC.
Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...
Macular degeneration is very common and affects an estimated ... from blood vessels as well as the number of abnormal blood vessels in the retina. Laser surgery: Shining a laser light beam on abnormal ...
Retinitis pigmentosa is a relatively rare genetic disorder (affecting 1 in 3,500 people), while age-related macular degeneration affects 7–8% of the population, and its incidence increases with age.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results